{{Rsnum
|rsid=12501856
|Gene=SLC34A2
|Chromosome=4
|position=25657986
|Orientation=plus
|GMAF=0.2649
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC34A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 41.6 | 43.4
| HCB | 8.8 | 43.1 | 48.2
| JPT | 5.3 | 44.2 | 50.4
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 14.0 | 86.0
| CHB | 8.8 | 43.1 | 48.2
| CHD | 12.0 | 33.3 | 54.6
| GIH | 15.8 | 44.6 | 39.6
| LWK | 0.0 | 3.6 | 96.4
| MEX | 12.1 | 51.7 | 36.2
| MKK | 0.6 | 18.6 | 80.8
| TSI | 12.7 | 46.1 | 41.2
| HapMapRevision=28
}}{{PMID|19119262|OA=1
}} may influence essential hypertension

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}